Effective and underprescribed: what about clozapine?

Abstract

Clinical psychiatry, especially pharmacological-based treatment regimens still face the problem of high rates of partial or non-responders to the various treatment strategies. So in schizophrenia, a serious psychiatric disease with regard to overall impairment of patients up to three-quarters will experience a relapse after their first episode and one-fifth is facing long-term symptoms often leading to disability and dramatically reduced quality of life and psychosocial outcome.